Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Moxonidine for Prevention of Post-ablation AFib Recurrences

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Spyridon Deftereos, G.Gennimatas General Hospital
ClinicalTrials.gov Identifier:
NCT01791699
First received: February 13, 2013
Last updated: May 4, 2014
Last verified: May 2014